Drug Patent Expirations in February 2012

Drug Patent Expirations in February 2012

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
VISUDYNE Qlt verteporfin 6,074,666 Feb 5, 2012
GANIRELIX ACETATE INJECTION Organon Usa Inc ganirelix acetate 4,801,577 Feb 5, 2012
ALINIA Romark nitazoxanide 5,387,598 Feb 7, 2012
AZILECT Teva rasagiline mesylate 5,786,390 Feb 7, 2012
AZILECT Teva rasagiline mesylate 5,387,612 Feb 7, 2012
AZILECT Teva rasagiline mesylate 5,457,133 Feb 7, 2012
LOVENOX Sanofi Aventis Us enoxaparin sodium RE38743 Feb 14, 2012
LOVENOX (PRESERVATIVE FREE) Sanofi Aventis Us enoxaparin sodium RE38743 Feb 14, 2012
LOVENOX (PRESERVATIVE FREE) Sanofi Aventis Us enoxaparin sodium 5,389,618 Feb 14, 2012
LOVENOX Sanofi Aventis Us enoxaparin sodium 5,389,618 Feb 14, 2012
ACANYA Dow Pharm Sci benzoyl peroxide; clindamycin phosphate 6,117,843 Feb 18, 2012
OPTISON Ge Healthcare albumin human 5,558,094 Feb 28, 2012

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com


   No Comments yet


  1. Steven Ma
      Feb 6, 2012

    I wonder how 12 patents/mo. compares to previous years? I am assuming it is a relatively high number considering how 2012 has been reported to be a big year in patent expiration..

Leave a Reply